Abramson, B. L. and Nelson, S. M. (2025) “PCSK9 Targeted Therapy to Lower Cholesterol and Reduce Cardiovascular Events”, Canadian Cardiology Today. Toronto, Canada, 1(1), pp. 20–25. doi: 10.58931/cct.2025.114.